Pioneer Hi Bred International issued US patent for 'soybean variety XBP05003'
Nevin Barich
ALEXANDRIA, Virginia
,
January 28, 2014
(U.S. Fed News)
–
United States Patent no. 8,637,743, issued on Jan. 28, was assigned to Pioneer Hi Bred International Inc (Johnston, Iowa).
"Soybean variety XBP05003" was invented by Nadejda N. Krasheninnik (Fargo, N.D.), Martin A. Fabrizius (Redwood Falls, Minn.) and Michael T. Roach (Redwood Falls, Minn.).
According to the abstract* released by the U.S. Patent & Trademark Office: "A novel soybean variety, designated XBP05003 is provided. Also provided are the seeds of soybean variety XBP05003, cells from soybean variety XBP05003, plants of soybean XBP05003, and plant parts of soybean variety XBP05003. Methods provided include producing a soybean plant by crossing soybean variety XBP05003 with another soybean plant, methods for introgressing a transgenic trait, a mutant trait, and/or a native trait into soybean variety XBP05003, methods for producing other soybean varieties or plant parts derived from soybean variety XBP05003, and methods of characterizing soybean variety XBP05003. Soybean seed, cells, plants, germplasm, breeding lines, varieties, and plant parts produced by these methods and/or derived from soybean variety XBP05003 are further provided."
The patent was filed on March 1, 2012, under Application No. 13/409,178.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8637743&OS=8637743&RS=8637743
For any query with respect to this article or any other content requirement, please contact Editor at htsyndication@hindustantimes.com
(c) 2014 US Fed News (HT Syndication)
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.